Numerical design of TiNbTaZrMoSn alloy preceded its manufacture and mechanical,
physico-chemical and in vitro characterisation. The specifications of the alloy required a
multi-objective optimisation including lower modulus of elasticity than c.p.Ti, high strength,
stabilised crystal structure with a low martensitic start temperature, a narrow solidification
range and high biocompatibility. The results reveal that there was a good match between the
bulk mechanical properties exhibited by the alloy experimentally and those predicted.
Regarding surface properties, independent of roughness effects, the oxide thickness and
surface zeta-potential, measured in biologically relevant electrolytes and at physiological pH,
appear as important factors in osteoblastic activity (i.e., cell proliferation, measured via DNA,
protein and metabolite content, and differentiation, via ALP levels), but not in cell adhesion
and viability. The thinner oxide layer and lower absolute value of surface zeta-potential on
the TiNbTaZrMoSn alloy explain its lesser osteogenic properties (i.e., inhibition of ALP
activity) compared to the c.p. Ti. This study demonstrates that the numerical models to
predict microstructure and bulk mechanical properties of -Ti alloys are robust, but that the
prediction of cellular bioactivity lags behind and still requires parameterisation to account for
features such as oxide layer composition and thickness, electro-chemical properties and
surface charge, and topography to optimise cell response in silico before committing to the
costly manufacture and deployment of these alloys in regenerative medicine.
Funding
Embedded Integrated Intelligent Systems for Manufacturing
Engineering and Physical Sciences Research Council
Mechanical, Electrical and Manufacturing Engineering
Published in
Journal of the Mechanical Behavior of Biomedical Materials
Volume
124
Publisher
Elsevier BV
Version
VoR (Version of Record)
Publisher statement
This is an Open Access Article. It is published by Elsevier under the Creative Commons Attribution 4.0 Unported Licence (CC BY). Full details of this licence are available at: http://creativecommons.org/licenses/by/4.0/